Search the Newsreel

Insider Buying: Rhinebeck Bancorp (NASDAQ:RBKB) EVP Acquires $59,699.90 in Stock

Rhinebeck Bancorp (NASDAQ:RBKB) Executive Vice President Michael Vitale recently purchased 4,834 shares of the company's stock for $59,699.90, increasing his total holdings by 27.5% to 22,414 shares. This transaction comes as RBKB shares rose 3.4% to $12.57, following a recent quarterly earnings report of …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

Pomerantz LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who suffered losses. The lawsuit alleges securities fraud after Embecta missed its Q2 2026 guidance and lowered its fiscal year guidance, primarily due to weak pen needle …

Rhinebeck Bancorp (RBKB) EVP purchases 4,834 shares in open-market buy

Michael Vitale, EVP and Head of Commercial Banking at Rhinebeck Bancorp, purchased 4,834 shares of RBKB common stock on August 6, 2026, at $12.35 per share. This transaction increased his direct holdings to 22,414 shares, including restricted stock that will vest annually starting April …

Becton Dickinson (NYSE: BDX) director awarded deferred stock rights

Becton Dickinson director Carrie L. Byington was granted 94 rights to Common Stock under the BD Deferred Compensation Plan, with each right valued at $165.62. This transaction increases her total plan rights to 3,810, including those acquired through dividend reinvestment. These rights convert one-for-one …

[10-Q] BECTON DICKINSON & CO Quarterly Earnings Report

Becton, Dickinson and Company (BDX) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. Key highlights include the completion of the spin-off of its former Biosciences and Diagnostic Solutions business and its combination with Waters Corporation, generating a …

Polen Touts ‘New BD,’ Product Innovation As Company Raises 2026 Earnings Outlook

Polen, representing BD (Becton, Dickinson and Company), is highlighting a "New BD" focus and significant product innovation. This strategic shift and new developments have led the company to raise its earnings outlook for 2026. The article indicates a positive financial forecast driven by these …

Ludwig Beck: Börsen-Aus bis Mitte August

Quebecor Q2 2026 Earnings Call Transcript

Becton, Dickinson beats Q3 2026 earnings and revenue estimates, updates full-year guidance.

Becton, Dickinson and Company (BDX) reported strong Q3 fiscal 2026 results, surpassing analyst expectations with an EPS of $3.23 and revenue of $4.98 billion. The company showed robust financial health, including a 44.6% increase in year-to-date free cash flow, and updated its full-year guidance, …

Bechtle Aktie: Gewinn steigt in Q2 2026 über 20% - Prognose nach oben angepasst (ZertifikateJournal)

Becker Milk's Yield Is Near 6.1% — a Quiet Property Company With Occasional Bursts of Extra Income

Becton Dickinson hebt Gewinnprognose für das Gesamtjahr an, nachdem Ergebnisse des dritten Quartals die Erwartungen übertreffen

Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views

Becton Dickinson (BDX) has raised its full-year earnings guidance following strong third-quarter results that surpassed Wall Street expectations. The medical device maker reported revenue gains across all its divisions, leading to an updated adjusted per-share earnings forecast of $12.62 to $12.72 for the year. …

Becton Dickinson and Company (BDX) sits just below fair value before earnings

The medical-technology stock has regained ground across weekly windows, but confirmation remains uneven before the Aug. 6 report.

EMBC Investors Have Opportunity to Lead Embecta Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements about its business and operations, particularly concerning its pen needle business and fiscal guidance, leading …

Rhinebeck Bancorp EVP Michael Vitale acquires 4,834 common shares valued at $59,704.9

Rhinebeck Bancorp EVP Michael Vitale has purchased 4,834 common shares at a price of $12.35 per share, totaling $59,704.9. This acquisition increases his direct stake in the company to 22,414 common shares. The information was generated by Public Technologies using AI, based on original …

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Becton Dickinson (BDX) reported revenue of $4.98 billion, down 9.6% over the same period last year. EPS came in at $3.23, compared to $3.68 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Informe de resultados: Becton Dickinson supera estimaciones del tercer trimestre de 2026 y mejora perspectivas

QUEBECOR INC CLASS B SV (QBR-B.TO) Q2 FY2026 earnings call transcript

Becton, Dickinson and Company 2026 Q3 - Results - Earnings Call Presentation (NYSE:BDX) 2026-08-06

This article announces the publication of Becton, Dickinson and Company's (BDX) Q3 2026 earnings call presentation. The slide deck was released in conjunction with their earnings call, providing details on their financial results for the quarter. The publication is handled by Seeking Alpha's transcripts …

Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates

Becton Dickinson (BDX) reported Q3 earnings of $3.23 per share and revenues of $4.98 billion, both exceeding Zacks Consensus Estimates. Despite outperforming expectations for the past four quarters, the stock has underperformed the S&P 500 this year, leading to a Zacks Rank #4 (Sell) …

Becton, Dickinson and Company Releases Q3 2026 Financial Results

Becton, Dickinson and Company reported stronger-than-expected Q3 2026 financial results, with adjusted earnings per share of $3.23 exceeding estimates and revenue reaching $4.98 billion. The company saw robust growth in its Interventional segment, and management provided optimistic guidance for the full fiscal year 2026. …

Why is Becton Dickinson stock climbing today?

Becton Dickinson (BDX) stock rose 1.8% in pre-open trading after the medical technology company reported fiscal Q3 2026 earnings that surpassed Wall Street expectations for both revenue and EPS. The company also raised its full-year fiscal 2026 adjusted diluted EPS guidance, signaling increased confidence …

Becton Dickinson Aktie steigt nach überzeugenden Quartalszahlen und angehobener Prognose

Becton, Dickinson: Bereinigter Gewinn und Umsatz im dritten Geschäftsquartal steigen; Prognose für bereinigtes EPS 2026 angehoben

Becton Dickinson beats estimates, raises guidance midpoint

Becton Dickinson and Company (NYSE:BDX) reported third-quarter results that surpassed analyst expectations for both earnings per share and revenue. The company posted adjusted EPS of $3.23 on revenue of $5.0 billion, exceeding estimates of $3.13 and $4.89 billion, respectively. Following these strong results, Becton …

Earnings Flash (BDX) Becton, Dickinson and Company Reports Q3 Revenue $4.98B

Becton, Dickinson and Company (BDX) reported its Q3 revenue at $4.98 billion. The company also expects its fiscal 2026 adjusted EPS to range from $12.62 to $12.72, aligning with FactSet estimates. Recent analyst activities include price target adjustments and new coverage with a "Buy" …

Becton Dickinson superaron 0.10$ las previsiones de BPA en el tercer trimestre del año

Becton Dickinson übertrifft Erwartungen und hebt Prognose an

Quebecor Q2 Earnings Miss Estimates Despite Revenue Beat

BD Reports Third Quarter Fiscal 2026 Financial Results

Revenue of $5.0 billion increased 5.4% as reported, 4.4% FXN GAAP and adjusted diluted EPS from continuing operations of $1.64 and $3.23, respectively Year-to-date cash from continuing operations increased 33.3% to $2.1 billion and free cash flow increased 44.6% to $1.7 billion Company updates …

Earnings Flash (QBR.A, QBR.B) Quebecor Inc. Reports Q2 Revenue C$1.44B, vs. FactSet Est of C$1.42B

QUEBECOR INC. REPORTS CONSOLIDATED RESULTS FOR SECOND QUARTER 2026

MONTRÉAL, Aug. 6, 2026 /CNW/ -- Quebecor Inc. ("Quebecor" or "the Corporation") today reported its consolidated financial results for the second quarter of 2026. Second quarter 2026 highlights In the second quarter of 2026, Quebecor's free cash flows1 were up $43.8 million (11.7%) compared …

Becton Dickinson and Co (BDX) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Embecta Corp. (EMBC): Deeply Undervalued Global Medical Device Company

Embecta Corp. (EMBC), a global medical device company specializing in diabetes care, is highlighted as a potentially undervalued opportunity. Despite operating in a defensive healthcare sector with stable demand, EMBC trades at attractive valuation levels, boasting strong cash generation, resilient profitability, and an improving …